Use of bone morphogenetic protein 2 on ectopic porous coated implants in the rat

Clinical Orthopaedics and Related Research

Volumn 345, Issue , 1997, Pages 219-228

  Cole, Brian J ^a,c   Bostrom, Mathias P G ^b   Pritchard, Traci L ^a   Sumner, Dale R ^a   Tomin, Emre ^b   Lane, Joseph M ^b   Weiland, Andrew J ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c Midwest Orthopaedics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HYDROXYAPATITE; RECOMBINANT PROTEIN; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; HISTOLOGY; IMPLANT; MORPHOMETRICS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RADIOGRAPHY; RAT; SCANNING ELECTRON MICROSCOPY;

EID: 0031469358     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199712000-00032     Document Type: Article

References (42)

1. Bloebaum RD, Dupont JA: Osteolysis from a press-fit hydroxyapatite-coated implant: A case study. J Arthroplasty 8:195-202, 1993.
2. Bobyn JD, Pilliar RM, Cameron HU, Weatherly GC: The optimum pore size for the fixation of porous-surfaced metal implants by the ingrowth of bone. Clin Orthop 150:263-270, 1980.
3. Bostrom MPG, Lane JM, Tomin E, Schildauer TAS, Berberain J: The use of recombinant human bone morphogenetic protein-2 in the rabbit ulnar non-union model: A radiographic, biomechanical and histological dose response study. Trans Orthop Res Soc 20:229, 1995.
4. Cameron HU: Six-year results with a microporous-coated metal hip prosthesis. Clin Orthop 208:81-83, 1986.
5. Campbell P, McKellop HY, Park SH, Malcolm A: Evidence of abrasive wear by particles from a hydroxyapatite coated hip prosthesis. Trans Orthop Res Soc 18:224, 1993.
6. Carlsson L, Regner L, Johansson C, Gottlander M, Herberts P: Bone response to hydroxyapatite-coated and commercially pure titanium implants in the human arthritic knee. J Orthop Res 12:274-285, 1994.
7. Cook SD, Thomas KA, Kay JF, Jarcho M: Hydroxyapatite-coated porous titanium for use as an orthopedic biologic attachment system. Clin Orthop 230:303-312, 1988.
8. D'Antonio JA. Capello WN, Crothers OD, Jaffe WL, Manley MT: Early clinical experience with hydroxyapatite-coated femoral implants. J Bone Joint Surg 74A:995-1008, 1992.
9. Galante JO, Rivero DP: The Biologic Basis of Bone Ingrowth in Titanium Fiber Composites. In Harris W (ed). Advanced Concepts in Total Hip Replacement. Thorofare, NJ, Slack 135-158, 1985.
10. Gazdag AR, Lane JM, Glaser D, Foster RA: Alternatives to autogenous bone graft: Efficacy and indications. J Am Acad Orthop Surg 3:1-14, 1995.
11. Geesink RGT, Hoefnagels NHM: Six-year results of hydroxyapatite-coated total hip replacement. J Bone Joint Surg 77B:534-547, 1995.
12. Gerhart TN, Kirker-Head CA, Kriz MJ, et al: Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 293:317-326, 1993.
13. Hermens KA, Kim WC, O'Carroll PF, Kabo M, Amstutz H: Bone morphogenetic protein and cancellous graft use in porous surfaced interface voids. Trans Orthop Res Soc 11:343, 1986.
14. Horisaka Y, Okamoto Y, Matsumoto N, et al: Subperiosteal implantation of bone morphogenetic protein adsorbed to hydroxyapatite. Clin Orthop 268: 303-312, 1991.
15. Kawai T, Mieki A, Ohno Y, et al: Osteoinductive activity of composites of bone morphogenetic protein and pure titanium. Clin Orthop 290:296-305, 1993.
16. Khouri RK, Koudsi B, Reddi H: Tissue transformation into bone in vivo. A potential practical application. JAMA 266:1953-1955, 1991.
17. Lintner F, Bohm G, Huber M, Scholz R: Histology of tissue adjacent to an HA-coated femoral prosthesis. J Bone Joint Surg 76B:824-830, 1994.
18. Lueck RA, Galante JO, Rostoker W, Ray RD: Development of an open pore metallic implant to permit attachment to bone. Surg Forum 20:456-457, 1969.
19. Maloney WJ, Harris WH: Comparison of a hybrid with an uncemented total hip replacement. A retrospective matched-pair study. J Bone Joint Surg 72A:1349-1352, 1990.
20. Maruyama M: Hydroxyapatite clay used to fill the gap between implant and bone. J Bone Joint Surg 77B:213-218, 1995.
21. McLaughlin RE, Reger SI, Bolander M, Eschenroeder HC: Enhancement of bone ingrowth by the use of bone matrix as a biologic cement. Clin Orthop 183:255-261, 1984.
22. Muschler GF, Hyodo A, Manning T, Kambic H, Easley K: Evaluation of human bone morphogenetic protein-2 in a canine spinal fusion model. Clin Orthop 308:229-240, 1994.
23. Muthukumaran N, Reddi AH: Bone matrix-induced local bone induction. Clin Orthop 200:159-164, 1985.
24. Pilliar RM, Cameron HU, Macnab I: Porous surface layered prosthetic devices. J Biomed Eng 10: 126-131, 1975.
25. Pilliar RM, Lee JM, Maniatopoulos C: Observations on the effect of movement on bone ingrowth into porous-surfaced implants. Clin Orthop 208:108-113, 1986.
26. Reddi A: Cell biology and biochemistry of endochondral bone development. Collagen Rel Res 1:209-226, 1981.
27. Ripamonti U, Ma SS, Cunningham NS, Yeates L, Reddi AH: Reconstruction of the bone-bone marrow organ by osteogenin, a bone morphogenetic protein, and demineralfzed bone matrix in calvarial defects of adult primates. Plast Reconstr Surg 91:27-36, 1993.
28. Stevenson S, Cunningham N, Toth J, Davy D, Reddi AH: Osteogenin in conjunction with ceramic induces bone formation in orthotopic segmental detects in rats. Trans Orthop Res Soc 17:579, 1992.
29. β1 absorbed on microcrystals of hydroxyapatite. Trans Orthop Res Soc 17:591, 1992.
30. Sumner DR, Turner TM, Puschio AF, et al: Enhancement of bone ingrowth by transforming growth factor-β. J Bone Joint Surg 77A:1135-1147, 1995.
31. Sumner DR, Turner TM, Urban R, Galante JO: Remodeling and ingrowth of bone at two years in a canine cementless total hip-arthroplasty model. J Bone Joint Surg 74A:239-250, 1992.
32. Szivek JA, Anderson PL, Dishongh TJ, DeYoung DW: Evaluation of factors affecting bonding rate of calcium phosphate ceramic coatings for in vivo strain gauge attachment. J Biomed Mater Res 33:121-132, 1996.
33. Takaoka K, Nakahara H, Hoshikawa H: Ectopic bone induction on porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin Orthop 234:250-254, 1988.
34. Urist MR: Bone: Formation by autoinduction. Science 150:893-899, 1965.
35. Urist MR, Silverman BF, Buring KK, Dubuc FL, Rosenberg JM: The bone induction principle. Clin Orthop 53:243-283, 1967.
36. Wang EA, Rosen V, Cordes P: Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 85:9484-9488, 1988.
37. Wang EA, Rosen V. D'Alessandro JS, et al: Recombinant human bone morphogenetic protein-2 induces bone formation. Proc Natl Acad Sci USA 87:2220-2224, 1990.
38. Wang GJ, Shen WJ, Chung KC, Balian G, McLaughlin RE: Demineralized bone matrix in revision arthroplasty. Trans Orthop Res Soc 14:336, 1989.
39. Welsh RP, Pilliar RM, Macnab I: The role of surface porosity in fixation to bone and acrylic. J Bone Joint Surg 53A:963-977, 1971.
40. Wozney JM, Rosen V, Celeste AJ, et al: Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534, 1988.
41. Wroblewski B, Taylor G, Siney P: Charnley low-friction arthroplasty; 19-25-year results. Orthopedics 15:421-424, 1992.
42. Yasko AW, Lane JM, Fellinger EJ, et al: The healing of segmental bone defects induced by recombinant human bone morphogenetic protein-2. J Bone Joint Surg 74A:659-671, 1992.